1. Home
  2. HTCO vs ANIK Comparison

HTCO vs ANIK Comparison

Compare HTCO & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTCO
  • ANIK
  • Stock Information
  • Founded
  • HTCO 2022
  • ANIK 1983
  • Country
  • HTCO Singapore
  • ANIK United States
  • Employees
  • HTCO N/A
  • ANIK N/A
  • Industry
  • HTCO
  • ANIK Medical/Dental Instruments
  • Sector
  • HTCO
  • ANIK Health Care
  • Exchange
  • HTCO NYSE
  • ANIK Nasdaq
  • Market Cap
  • HTCO N/A
  • ANIK 243.4M
  • IPO Year
  • HTCO N/A
  • ANIK 1993
  • Fundamental
  • Price
  • HTCO $1.11
  • ANIK $15.30
  • Analyst Decision
  • HTCO
  • ANIK Buy
  • Analyst Count
  • HTCO 0
  • ANIK 2
  • Target Price
  • HTCO N/A
  • ANIK $22.00
  • AVG Volume (30 Days)
  • HTCO 257.4K
  • ANIK 89.0K
  • Earning Date
  • HTCO 01-01-0001
  • ANIK 03-12-2025
  • Dividend Yield
  • HTCO N/A
  • ANIK N/A
  • EPS Growth
  • HTCO N/A
  • ANIK N/A
  • EPS
  • HTCO N/A
  • ANIK N/A
  • Revenue
  • HTCO $108,176,683.00
  • ANIK $119,907,000.00
  • Revenue This Year
  • HTCO N/A
  • ANIK N/A
  • Revenue Next Year
  • HTCO N/A
  • ANIK $8.50
  • P/E Ratio
  • HTCO N/A
  • ANIK N/A
  • Revenue Growth
  • HTCO 13.56
  • ANIK N/A
  • 52 Week Low
  • HTCO $0.21
  • ANIK $14.95
  • 52 Week High
  • HTCO $4.50
  • ANIK $29.12
  • Technical
  • Relative Strength Index (RSI)
  • HTCO N/A
  • ANIK 39.25
  • Support Level
  • HTCO N/A
  • ANIK $15.02
  • Resistance Level
  • HTCO N/A
  • ANIK $15.62
  • Average True Range (ATR)
  • HTCO 0.00
  • ANIK 0.68
  • MACD
  • HTCO 0.00
  • ANIK -0.08
  • Stochastic Oscillator
  • HTCO 0.00
  • ANIK 25.11

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: